What the corpus says
Ovagen bioregulator peptide (Khavinson school). Limited primary literature; full source PDFs preserved in the dossier.
mechanism confidence: very low
PubMed papers
0
in our PubMed map
Russian full-text sources
21
Russian full-text PDFs
Archive notes
4
from archive synthesis
Confidence
very low
archive rating
Research synthesis
Mechanism
Polypeptide fraction from bovine ovaries. tissue-specific reproductive bioregulator. Direct primary literature on Ovagen® product is sparse. Most adjacent literature covers:
- constant light exposure → anovulation + female reproductive cancer (Anisimov 2003)
- melatonin in obstetrics/gynaecology (Gafarova-Maltseva 2014)
- goat embryo cryopreservation quality (Aksenova-Aibazov-Seitov 2013)
- thymosin-α1 effects on B-cells in pigs (Molyanova 2013)
- goat polyovulation induction for embryo transplantation. uses peptide combinations (Aksenova 2013). The Khavinson-school ovarian peptide concept is established but under-published on dedicated Ovagen® product studies.
Key findings
- Adjacent: goat polyovulation induction. peptide combinations used to overcome donor variability (Aksenova 2013)
- Adjacent: constant light exposure effects on anovulation and cancer risk (Anisimov 2003)
- Adjacent: embryo cryopreservation quality (Aksenova 2013)
- No DIRECT Ovagen® product studies identified in CyberLeninka audit
Evidence quality
grade: Very low. No direct Ovagen® studies. Adjacent reproductive biology literature is strong but not directly about this compound.
Open questions
- Dedicated Ovagen® pharmacology
- Clinical use in human reproductive medicine (anovulation, IVF adjunct)
- Comparison with gonadotropins
Russian full-text papers (CyberLeninka) · 21
cyberleninka_00.pdfcyberleninka_01.pdfcyberleninka_02.pdfcyberleninka_03.pdfcyberleninka_04.pdfcyberleninka_05.pdfcyberleninka_06.pdfcyberleninka_07.pdfcyberleninka_08.pdfcyberleninka_09.pdfcyberleninka_10.pdfcyberleninka_11.pdfcyberleninka_12.pdfcyberleninka_13.pdfcyberleninka_14.pdfcyberleninka_15.pdfcyberleninka_16.pdfcyberleninka_17.pdfcyberleninka_18.pdfcyberleninka_19.pdfcyberleninka_20.pdf
Papers indexed on PubMed
no PubMed-indexed literature in the corpus.
Reviewed against the archive corpora on 2026-09-16. Source-grounded. No clinical claims. Synthesis prose may preserve published experimental context from papers; that is research history, not a recommendation.